International Chair on Cardiometabolic Risk

CMR Short Reviews
- The Concept of CMR
  Historical background on global cardiometabolic risk, epidemiological aspects of obesity and type 2 diabetes, ABCs of cardiovascular disease risk factors, intra-abdominal adiposity, metabolic syndrome and contribution to cardiometabolic risk.
- Evaluating CMR
  Research and clinical tools to identify individuals with excess intra-abdominal adiposity and quantify their risk of diabetes and cardiovascular disease (global cardiometabolic risk).
- Managing CMR
  Notions and practical tools to better manage the abdominally obese patient with excess intra-abdominal adiposity and related clustering abnormalities.
Documentation Centre
- Slides, videos and more

News

July 02, 2009 Cardiovascular Disease, Inflammation, Metabolic Syndrome, News

Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia. Diabetes Care 2009;32:486-92

Trøseid M, Seljeflot I, Hjerkinn EM, Arnesen H.

This study investigated some inflammatory markers as potential predictors of cardiovascular events in a population of elderly men with/without the metabolic syndrome (n=563). Results of this study revealed that interleukin-18 was an independent predictor of cardiovascular events in individuals with the metabolic syndrome and also in individuals with elevated fasting glucose concentrations. This finding suggests that inflammation and hyperglycemia might both have deleterious effects on cardiovascular risk.

Pubmed article

The content of this website is provided for educational and informational purposes only and is not to be used for medical advice, diagnosis or treatment. Use of this site is subject to the terms and conditions contained in our Legal Notices.